Listen to this article

Shares in CSL hit a record intraday peak on Thursday and closed at their highest level on record as investors continued to bask in the afterglow of the Australian biotech company’s latest earnings report.

On Thursday the stock leaped as much as 4.4 per cent to A$123.24 per share before paring back to close the afternoon session at a still record level of A$122.40, up 3.7 per cent on the day.

By comparison, the benchmark S&P/ASX 200 index ended the day up just 0.1 per cent.

Thursday’s close brings shares in CSL 7 per cent higher in the week so far. They leaped as much as 3 per cent on Wednesday after the company reported half-year profits had risen 12 per cent year on year.

On January 19 the stocked jumped as much as 11 per cent after the company raised its profit forecast for the 2017 financial year as high as 20 per cent.